These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2225080)

  • 1. Thymic hormone modulation of age-induced changes in the induction of graft-versus-host disease by DBA/2J lymphocytes.
    Fast LD; Kouttab NM; Badamchian M; Goldstein AL
    Cell Immunol; 1990 Nov; 131(1):232-41. PubMed ID: 2225080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DBA/2J and DBA/2Ha lymphocytes differ in their ability to induce graft-vs-host disease.
    Fast LD
    J Immunol; 1989 Oct; 143(8):2489-93. PubMed ID: 2794505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of IL-2-activated veto cells.
    Fast LD
    J Immunol; 1992 Sep; 149(5):1510-5. PubMed ID: 1354678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a single non-H-2 gene regulating graft-versus-host disease response.
    Fast LD
    J Immunol; 1990 Jun; 144(11):4177-82. PubMed ID: 2111342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of a murine recipient anti-donor effector cell responsible for the development of chronic graft-versus-host disease.
    Fast LD
    J Immunol; 1991 Sep; 147(6):1731-8. PubMed ID: 1909729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease.
    Onoe Y; Harada M; Tamada K; Abe K; Li T; Tada H; Nomoto K
    Immunology; 1998 Oct; 95(2):248-56. PubMed ID: 9824483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from lethal graft-vs.-host disease by donor stem cell repopulation.
    Rozendaal L; Pals ST; Melief CJ; Gleichmann E
    Eur J Immunol; 1992 Feb; 22(2):575-9. PubMed ID: 1347016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes.
    Thiele DL; Eigenbrodt ML; Bryde SE; Eigenbrodt EH; Lipsky PE
    J Clin Invest; 1989 Dec; 84(6):1947-56. PubMed ID: 2531761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells.
    Krenger W; Rossi S; Piali L; Holländer GA
    Blood; 2000 Jul; 96(1):347-54. PubMed ID: 10891472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease.
    Tschetter JR; Mozes E; Shearer GM
    J Immunol; 2000 Nov; 165(10):5987-94. PubMed ID: 11067962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyric acid derivative induces allospecific T cell anergy and prevents graft-versus-host disease.
    Gilbert KM; Boger S; Fifer EK
    Immunopharmacol Immunotoxicol; 2003 Feb; 25(1):13-27. PubMed ID: 12675196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
    Nguyen V; Rus H; Chen C; Rus V
    J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cytokine expression in acute and chronic murine graft-versus-host-disease.
    Allen RD; Staley TA; Sidman CL
    Eur J Immunol; 1993 Feb; 23(2):333-7. PubMed ID: 8436168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-18 prevents the development of chronic graft-versus-host disease in mice.
    Okamoto I; Kohno K; Tanimoto T; Iwaki K; Ishihara T; Akamatsu S; Ikegami H; Kurimoto M
    J Immunol; 2000 Jun; 164(11):6067-74. PubMed ID: 10820292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The parent-into-F1 murine model in the study of lupus-like autoimmunity and CD8 cytotoxic T lymphocyte function.
    Soloviova K; Puliaiev M; Foster A; Via CS
    Methods Mol Biol; 2012; 900():253-70. PubMed ID: 22933073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymic hormones in radiation-induced immunodeficiency. I. Induction of mature interleukin 1 responsive cell in the thymus by thymosin fraction 5.
    Neta R; MacVittie TJ; Schwartz GN; Douches SD
    Cell Immunol; 1985 Sep; 94(2):480-90. PubMed ID: 3875422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
    Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
    J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of murine chronic graft-versus-host disease by the chloroform extract of Tripterygium wilfordii Hook f.
    Asano K; Yu Y; Kasahara T; Hisamitsu T
    Transpl Immunol; 1997 Dec; 5(4):315-9. PubMed ID: 9504154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.